BR0315813A - Antitumor combinations comprising proteins and chemotherapeutic agents - Google Patents

Antitumor combinations comprising proteins and chemotherapeutic agents

Info

Publication number
BR0315813A
BR0315813A BR0315813-6A BR0315813A BR0315813A BR 0315813 A BR0315813 A BR 0315813A BR 0315813 A BR0315813 A BR 0315813A BR 0315813 A BR0315813 A BR 0315813A
Authority
BR
Brazil
Prior art keywords
proteins
chemotherapeutic agents
antitumor combinations
antitumor
protein
Prior art date
Application number
BR0315813-6A
Other languages
Portuguese (pt)
Inventor
Alberto Bartorelli
Daniela Concas
Adalberto Archai Chirra
Carlo Mor
Original Assignee
Zetesis Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zetesis Spa filed Critical Zetesis Spa
Publication of BR0315813A publication Critical patent/BR0315813A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/37—Digestive system
    • A61K35/407—Liver; Hepatocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Physiology (AREA)
  • Virology (AREA)
  • Nutrition Science (AREA)
  • Organic Chemistry (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

"COMBINAçõES ANTITUMOR COMPREENDENDO PROTEìNAS E QUIMIOTERAPêUTICOS". A presente invenção refere-se a composições farmacêuticas contendo: a. extrato perclórico de fígado de cabra contendo a proteína UK 114; b. ciclofosfamida; c. doxorrubicina ou outras antraciclinas; d. 5-fluorouracila, na forma de combinação para o uso simultâneo, separado ou seq³encial em quimioterapia."ANTITUMOR COMBINATIONS UNDERSTANDING PROTEIN AND CHEMOTHERAPEUTICS". The present invention relates to pharmaceutical compositions containing: a. goat liver perchloric extract containing the UK protein 114; B. cyclophosphamide; ç. doxorubicin or other anthracyclines; d. 5-fluorouracil, in combination form for simultaneous, separate or sequential use in chemotherapy.

BR0315813-6A 2002-10-30 2003-10-27 Antitumor combinations comprising proteins and chemotherapeutic agents BR0315813A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT002307A ITMI20022307A1 (en) 2002-10-30 2002-10-30 ANTI-TUMORAL ASSOCIATIONS INCLUDING PROTEINS AND CHEMOTHERAPIES.
PCT/EP2003/011912 WO2004039393A1 (en) 2002-10-30 2003-10-27 Anti-tumor combinations comprising proteins and chemotherapeutics

Publications (1)

Publication Number Publication Date
BR0315813A true BR0315813A (en) 2005-09-20

Family

ID=32211391

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0315813-6A BR0315813A (en) 2002-10-30 2003-10-27 Antitumor combinations comprising proteins and chemotherapeutic agents

Country Status (8)

Country Link
KR (1) KR20050075761A (en)
CN (1) CN1708315A (en)
AU (1) AU2003285304A1 (en)
BR (1) BR0315813A (en)
IT (1) ITMI20022307A1 (en)
MX (1) MXPA05004514A (en)
RU (1) RU2005113167A (en)
WO (1) WO2004039393A1 (en)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1244879B (en) * 1990-12-11 1994-09-12 Alberto Bartorelli EXTRACTS FROM ANIMAL TISSUES, USEFUL IN THERAPY AND DIAGNOSTICS.
US5283238A (en) * 1992-04-24 1994-02-01 Immtech International, Inc. Methods of treating cancer using modified C-reactive protein
IT1270618B (en) * 1994-07-14 1997-05-07 Zetesis Spa PROTEIN WITH ANTI-TUMOR ACTIVITY
ITMI991384A1 (en) * 1999-06-22 2000-12-22 Zetesis Spa USE OF UK 114 PROTEIN TO INHIBIT ORGAN TRANSPLANT REJECTION

Also Published As

Publication number Publication date
WO2004039393A1 (en) 2004-05-13
MXPA05004514A (en) 2005-07-26
AU2003285304A1 (en) 2004-05-25
KR20050075761A (en) 2005-07-21
CN1708315A (en) 2005-12-14
RU2005113167A (en) 2005-11-20
ITMI20022307A1 (en) 2004-04-30

Similar Documents

Publication Publication Date Title
TR200002299T2 (en) Epothilon compositions.
BRPI0417823A (en) methods for using probiotic bifidobacteria for pets
ES2149044T3 (en) PAROXETINE METHANOSULFONATE.
WO2006038208A3 (en) Agents capable of downregulating an msf-a - dependent hif-1α and use thereof in cancer treatment
BR0111667A (en) New compounds
CY1112687T1 (en) METHOD FOR USING DICTIONARIES AND COMPOSITIONS THAT INCLUDE
NO324250B1 (en) Diazabicyclic compounds, pharmaceutical compositions comprising these and their use
NO20025954D0 (en) Glykopeptidfosfonatderivater
GT200600520A (en) ANTIBACTERIAL AGENTS
ATE519494T1 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING BOTULINUM TOXIN
DK1263720T3 (en) Acetidine derivatives, their preparation, and pharmaceutical compositions containing the same
RS50660B (en) Dihydrotetrabenazines and pharmaceutical compositions containing them
IL192631A (en) Composition comprising isolated antibody or functional fragment thereof, pharmaceutical compositions and kit comprising the same
IL194550A (en) Isolated antibody or fragment thereof that binds to human protein tyrosine phosphatase beta, pharmaceutical compositions containing the same and uses thereof
WO2007044809A3 (en) Albumin-free botulinum toxin based pharmaceutical compositions containing a hyaluronidase and methods of use
HK1083296A1 (en) Enteral composition for the prevention and/or treatment of sepsis
GT200800107A (en) ORAL FORMULATIONS THAT INCLUDE TIGECICLINE
TW200630343A (en) 2-Alkoxy-3,4,5-trihydroxy-alkylamides, preparation thereof, compositions containing them and use thereof
ATE240303T1 (en) 1,2,4-TRIAZOLE-3-THIONE COMPOUNDS
CL2004001012A1 (en) COMPOUNDS DERIVED FROM MACROLIDS OF 14 OR 15 MEMBERS, REPLACED IN POSITION 4 "; PROCEDURE FOR PREPARATION; PHARMACEUTICAL COMPOSITION THAT INCLUDES IT; AND ITS USE FOR THE TREATMENT OR PROFILAXIS OF SYSTEMIC MICROBIAL OR TOPICAL INFECTIONS
ATE388960T1 (en) GLYCOPEPTIDE DERIVATIVES WITH CARBOXY SACCHARIDES
BR0317623A (en) Escitalopram, pharmaceutical composition, and use of escitalopram hydrobromide
DE602006019057D1 (en) POLY-EPITOP PEPTIDE DERIVED FROM THE THYMIDYLATE SYNTHASE WITH IMMUNOLOGICAL AND ANTI-TUMOR ACTIVITY
BR0315813A (en) Antitumor combinations comprising proteins and chemotherapeutic agents
AU2001248994A1 (en) Use of substances with oxytocin activity against climacteric disorders

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal acc. article 33 of ipl - extension of time limit for request of examination expired